← Back to catalogue

AGILON® XO trial glenosphere

FDA UDI

Class II (US FDA UDI)

by implantcast GmbH

Identity

Trade Name
AGILON® XO trial glenosphere FDA UDI
Generic Name
Reverse shoulder head prosthesis trial FDA UDI
Model / Reference
78034046 FDA UDI

Identifiers

Primary DI / UDI-DI
04048844426118 FDA UDI
FDA Product Code
PHX FDA UDI
HSD FDA UDI
GMDN Term
Reverse shoulder head prosthesis trial FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
888.3660 FDA UDI
888.3690 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI
Sterilization Method
Moist Heat or Steam Sterilization FDA UDI

Category: Reverse shoulder head prosthesis trial

AGILON® XO trial glenosphere by implantcast GmbH — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Reverse shoulder head prosthesis trial.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
implantcast GmbH

Sources (1)

  • FDA UDI e2c0abb5-59fc-4dff-b9c3-5cbf891a74e2 33 fields · synced Jun 6, 2026